Conference on Retroviruses and Opportunistic Infections (CROI 2019) 4–7 March, 2019
20 May 2019. Related: Conference reports.
CROI 26 (Retrovirus) 2019
INSTI and weight gain: reports from CROI 2019
20 May 2019. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
B/F/TAF suitable for children from six years of age
20 May 2019. Related: Conference reports, Paediatric care.
Conference on Retroviruses and Opportunistic Infections (CROI 2019): third reports
30 April 2019. Related: Conference reports.
Paediatric dolutegravir update
30 April 2019. Related: Conference reports, Paediatric care.
Other cure related studies at CROI 2019
30 April 2019. Related: Conference reports, Cure-related research.
Conference on Retroviruses and Opportunistic Infections (CROI 2019): second reports
28 March 2019. Related: Conference reports.
Maturation inhibitor GSK’232 reduces viral load by –1.5 log at day 10
28 March 2019. Related: Conference reports, Antiretrovirals.
Capsid inhibitor GS-6207 shows potential for 3-monthly injections
28 March 2019. Related: Conference reports, Antiretrovirals.
First phase 1 results from bNAb PGT121 in HIV positive people
28 March 2019. Related: Conference reports, Antiretrovirals.
Dolutegravir/3TC dual ART is as effective at lowest viral load cut-off as triple therapy in GEMINI studies
28 March 2019. Related: Conference reports, Antiretrovirals, Treatment strategies.
Same-day ART is effective in San Francisco Rapid-ART clinic
28 March 2019. Related: Conference reports, Antiretrovirals, Treatment strategies.
Integrase inhibitors and neural tube defects: more data still needed
28 March 2019. Related: Conference reports, Pregnancy.
Double-dose levonorgestrel implant does not overcome interaction with efavirenz
28 March 2019. Related: Conference reports, Women's health, PK and drug interactions.
Efavirenz and rifampicin together reduce levels of injectable contraception
28 March 2019. Related: Conference reports, Women's health, PK and drug interactions.
Bedaquiline and delamanid safe when given together to treat drug resistant TB
28 March 2019. Related: Conference reports, TB coinfection.
Isoniazid preventative therapy in HIV positive pregnant women not linked to poor outcomes
28 March 2019. Related: Conference reports, TB coinfection.
Conference on Retroviruses and Opportunistic Infections (CROI 2019): early reports
12 March 2019. Related: Conference reports.
UK patient likely to be the second person cured of HIV: two further cases at CROI 2019 of HIV remission after allogenic stem cell transplants
12 March 2019. Related: Conference reports, Cure-related research.
Phase 3 results with dual therapy cabotegravir/rilpivirine long-acting injections: ATLAS and FLAIR studies
12 March 2019. Related: Conference reports, Antiretrovirals.
Viral reservoir can explain persistent low level viraemia with good adherence on ART
12 March 2019. Related: Conference reports, Treatment strategies.
Dolutegravir suppresses viral load faster than efavirenz in late pregnancy: results from DolPHIN-2
12 March 2019. Related: Conference reports, Pregnancy.
Raltegravir achieves swifter viral load suppression in pregnancy than efavirenz
12 March 2019. Related: Conference reports, Pregnancy.
New option for PrEP – TAF/FTC is non-inferior to TDF/FTC: results of phase 3 DISCOVER study
12 March 2019. Related: Conference reports, HIV prevention and transmission.
Dolutegravir can be given with 3HP to prevent TB without dose adjustment
12 March 2019. Related: Conference reports, PK and drug interactions, TB coinfection.
Double doses of darunavir given with rifampicin lead to high rates of hepatoxicity
12 March 2019. Related: Conference reports, PK and drug interactions, TB coinfection.
Shared housing compared to living alone: higher CD4, lower viral load and reduced inflammation in macaques
12 March 2019. Related: Conference reports, Coinfections and complications.
Selected webcasts at CROI 2019
12 March 2019. Related: Conference reports, PK and drug interactions.
i-Base Fit for Purpose report launched at CROI 2019
12 March 2019. Related: Supplements, Conference reports.
Pre-CROI Community HIV Cure Workshop 2019
12 March 2019. Related: Conference reports, Cure-related research.